$1.84
-0.14-6.84%
At close: -
$2.01
0.179.24%
After Hours: Apr 3, 4:42 PM EDT
Inhibikase Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Inhibikase Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
IKT | Inhibikase Therapeutics | -$0.73 | -$0.11 | — | — | $0.00 | — | — | — | 05/14/2025 | Get Alert |
IKT | Inhibikase Therapeutics | -$0.64 | -$0.10 | — | — | $1.00K | — | — | — | 04/21/2025 | Get Alert |
IKT | Inhibikase Therapeutics | -$0.75 | -$0.67 | -$0.65 | 2.99% | $79.57K | — | $0.00 | — | 11/14/2024 | Get Alert |
IKT | Inhibikase Therapeutics | -$0.94 | -$0.67 | -$0.66 | 1.49% | $116.41K | — | $0.00 | — | 08/14/2024 | Get Alert |
IKT | Inhibikase Therapeutics | -$0.96 | -$0.79 | -$0.73 | 7.59% | $64.52K | — | $0.00 | — | 05/15/2024 | Get Alert |
IKT | Inhibikase Therapeutics | -$1.02 | -$0.85 | -$0.64 | 24.71% | $63.57K | — | $1.00K | — | 03/27/2024 | Get Alert |
IKT | Inhibikase Therapeutics | -$1.08 | -$1.19 | -$0.86 | 27.73% | $7.29K | — | $79.57K | — | 11/14/2023 | Get Alert |
IKT | Inhibikase Therapeutics | -$1.08 | -$0.92 | -$1.11 | -20.65% | $6.55K | — | $116.41K | — | 08/14/2023 | Get Alert |
IKT | Inhibikase Therapeutics | -$1.08 | -$0.84 | -$0.96 | -14.29% | $46.03K | — | $64.52K | — | 05/15/2023 | Get Alert |
IKT | Inhibikase Therapeutics | -$1.20 | -$1.14 | -$1.02 | 10.53% | $1.94M | — | $63.57K | — | 03/31/2023 | Get Alert |
IKT | Inhibikase Therapeutics | -$1.08 | -$1.08 | -$1.08 | 0.00% | $328.46K | $200.00K | $7.29K | -96.35% | 11/14/2022 | Get Alert |
IKT | Inhibikase Therapeutics | -$1.32 | -$1.14 | -$1.08 | 5.26% | $1.36M | $300.00K | $6.55K | -97.82% | 08/12/2022 | Get Alert |
IKT | Inhibikase Therapeutics | -$1.56 | -$1.02 | -$1.08 | -5.88% | $1.41M | $300.00K | $46.03K | -84.66% | 05/16/2022 | Get Alert |
IKT | Inhibikase Therapeutics | -$0.90 | -$1.02 | -$1.20 | -17.65% | $170.42K | $300.00K | $1.94M | 548.00% | 03/31/2022 | Get Alert |
IKT | Inhibikase Therapeutics | -$0.48 | -$0.84 | -$1.08 | -28.57% | $37.68K | $328.00K | $328.46K | 0.14% | 11/15/2021 | Get Alert |
IKT | Inhibikase Therapeutics | -$0.30 | -$2.28 | -$1.32 | 42.11% | $219.59K | $300.00K | $1.36M | 354.33% | 08/16/2021 | Get Alert |
IKT | Inhibikase Therapeutics | -$0.42 | — | -$1.56 | — | — | — | $1.41M | — | 05/17/2021 | Get Alert |
IKT | Inhibikase Therapeutics | -$0.30 | — | -$0.90 | — | — | — | $170.42K | — | 04/01/2021 | Get Alert |
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-14 | $-0.65 | $-0.67 | 2.99 % |
Q2 | 2024-08-14 | $-0.66 | $-0.67 | 1.49 % |
Q1 | 2024-05-15 | $-0.73 | $-0.79 | 7.59 % |
Q4 | 2024-03-27 | $-0.64 | $-0.85 | 24.7 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2022-11-14 | $7.29K | $200.00K | -96.4 % |
Q2 | 2022-08-12 | $6.55K | $300.00K | -97.8 % |
Q1 | 2022-05-16 | $46.03K | $300.00K | -84.7 % |
Q4 | 2022-03-31 | $1.94M | $300.00K | 548.0 % |
Inhibikase Therapeutics (IKT) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
The Actual EPS was $-0.65, which beat the estimate of $-0.67.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.